Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 2 , Pages 180-181, March 2009

Advancing Alzheimer's disease drug review as a national priority

  • Daniel P. Perry

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: 202-293-2856; Fax: 202-785-8574

Chairman, ACT-AD Coalition, Washington, DC, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1552-5260(08)02868-9

doi:10.1016/j.jalz.2008.08.007

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 2 , Pages 180-181, March 2009

Article Tools